NIAID Banner Logo Image

Other Viruses Citation List:

April 16 - April 29, 2010

Hepatitis C Virus

1. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.

Gao M, Nettles RE, Belema M, Snyder LB, Nguyen VN, Fridell RA, Serrano-Wu MH, Langley DR, Sun JH, O'Boyle Ii DR, Lemm JA, Wang C, Knipe JO, Chien C, Colonno RJ, Grasela DM, Meanwell NA, Hamann LG.

Nature. 2010 Apr 21. [Epub ahead of print]PMID: 20410884 [PubMed - as supplied by publisher]

2. Synthesis of 2'-fluoro and 2',4'-dimethyl pyrimidine C-nucleoside analogues as potential anti-HCV agents.

Liu LJ, Hong JH.

Nucleosides Nucleotides Nucleic Acids. 2010 Mar;29(3):216-27.PMID: 20408052 [PubMed - in process]

3. In Vitro Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses.

Selvam P, Murgesh N, Chandramohan M, De Clercq E, Keyaerts E, Vijgen L, Maes P, Neyts J, Ranst MV.

Indian J Pharm Sci. 2008 Jan;70(1):91-4.PMID: 20390088 [PubMed - in process]

Herpes Simplex Virus

4. Inhibition of HSV-1 Attachment, Entry, and Cell-to-Cell Spread by Functionalized Multivalent Gold Nanoparticles.

Baram-Pinto D, Shukla S, Gedanken A, Sarid R.

Small. 2010 Apr 14. [Epub ahead of print]PMID: 20394070 [PubMed - as supplied by publisher]

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2021